John J. Nemunaitis, M.D.
Executive Medical Director
Mary Crowley Cancer Research Center
Dallas, TX

John Nemunaitis, M.D., Oncologist and Executive Medical Director of the Mary Crowley Cancer Research Centers (MCCRC), has been exploring novel targeting therapies for treating cancer patients for over 20 years. John received his B.A. and M.D. degrees from Case Western Reserve University. He completed his residency at Boston City Hospital and then performed his Hematology and Oncology fellowship at the University of Washington and the Fred Hutchinson Cancer Research Center in Seattle from 1988 to 1993. John came to Dallas in 1993 to establish the clinical research program at Texas Oncology Physicians Association (TOPA). He later established a not-for-profit translational research program (the MCCRC). He is a committee member of Western Institutional Biosafety Committee (IBC) and recently co-founded a molecular vaccine base with GMP manufacturing capacity called Gradalis, Inc. John has authored over 230 peer-reviewed publications, over 30 book chapters and has instituted study establishment of over 300 trials and overseen FDA sponsored experimental treatment of nearly 3500 cancer patients at the MCCRC. His research focus is clinical in orientation and involves determination of molecular signals in order to optimize targeted therapy, development of RNAi based therapeutics and vaccine approaches.